5XVF

Crystal Structure of PAK4 in complex with inhibitor CZH062


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.655 Å
  • R-Value Free: 0.251 
  • R-Value Work: 0.194 

wwPDB Validation  3D Report Full Report


This is version 1.0 of the entry. See complete history

Literature

Structure-Based Design of 6-Chloro-4-aminoquinazoline-2-carboxamide Derivatives as Potent and Selective p21-Activated Kinase 4 (PAK4) Inhibitors.

Hao, C.Zhao, F.Song, H.Guo, J.Li, X.Jiang, X.Huan, R.Song, S.Zhang, Q.Wang, R.Wang, K.Pang, Y.Liu, T.Lu, T.Huang, W.Wang, J.Lin, B.He, Z.Li, H.Li, F.Zhao, D.Cheng, M.

(2018) J. Med. Chem. 61: 265-285

  • DOI: 10.1021/acs.jmedchem.7b01342
  • Primary Citation of Related Structures:  5XVA, 5XVG

  • PubMed Abstract: 
  • Herein, we report the discovery and characterization of a novel class of PAK4 inhibitors with a quinazoline scaffold. Based on the shape and chemical composition of the ATP-binding pocket of PAKs, we chose a 2,4-diaminoquinazoline series of inhibitor ...

    Herein, we report the discovery and characterization of a novel class of PAK4 inhibitors with a quinazoline scaffold. Based on the shape and chemical composition of the ATP-binding pocket of PAKs, we chose a 2,4-diaminoquinazoline series of inhibitors as a starting point. Guided by X-ray crystallography and a structure-based drug design (SBDD) approach, a series of novel 4-aminoquinazoline-2-carboxamide PAK4 inhibitors were designed and synthesized. The inhibitors' selectivity, therapeutic potency, and pharmaceutical properties were optimized. One of the best compounds, 31 (CZh226), showed remarkable PAK4 selectivity (346-fold vs PAK1) and favorable kinase selectivity profile. Moreover, this compound potently inhibited the migration and invasion of A549 tumor cells by regulating the PAK4-directed downstream signaling pathways in vitro. Taken together, these data support the further development of 31 as a lead compound for PAK4-targeted anticancer drug discovery and as a valuable research probe for the further biological investigation of group II PAKs.


    Organizational Affiliation

    Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University , Shenyang 110016, China.




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
Molecule Chains Sequence Length Organism Details
Serine/threonine-protein kinase PAK 4
A
290 Homo sapiens Gene Names: PAK4 (KIAA1142)
EC: 2.7.11.1
Find proteins for O96013 (Homo sapiens)
Go to Gene View: PAK4
Go to UniProtKB:  O96013
Small Molecules
Ligands 1 Unique
ID Chains Name / Formula / InChI Key 2D Diagram 3D Interactions
8FR
Query on 8FR

Download SDF File 
Download CCD File 
A
2-(4-azanylpiperidin-1-yl)-6-chloranyl-N-(1-methylimidazol-4-yl)quinazolin-4-amine
C17 H20 Cl N7
FFRWUFYTZPMLTK-UHFFFAOYSA-N
 Ligand Interaction
Modified Residues  1 Unique
ID Chains Type Formula 2D Diagram Parent
SEP
Query on SEP
A
L-PEPTIDE LINKING C3 H8 N O6 P SER
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.655 Å
  • R-Value Free: 0.251 
  • R-Value Work: 0.194 
  • Space Group: P 41 21 2
Unit Cell:
Length (Å) Angle (°)
a = 65.404 α = 90.00
b = 65.404 β = 90.00
c = 180.863 γ = 90.00
Software Package:
Software Name Purpose
DENZO data collection
PDB_EXTRACT data extraction
PHENIX refinement
HKL-2000 data scaling

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History 

Deposition Data

  • Deposited Date: 2017-06-27 
  • Released Date: 2018-02-07 
  • Deposition Author(s): Zhao, F., Li, H.

Revision History 

  • Version 1.0: 2018-02-07
    Type: Initial release